Danish biotech company Gubra launched a new business unit called Gubra Ventures on February 10, 2026, focused on creating independent biotechnology companies.134
Zoë Johnson has been appointed as director to lead Gubra Ventures.1345
This launch supports Gubra's transformation from a preclinical CRO to a dual-business model emphasizing discovery partnerships and proprietary assets like UCN2 for obesity.2
Sources:
1. https://medwatch.com/News/Pharma_Biotech/article19003660.ece
2. https://www.ainvest.com/news/gubra-investor-biotech-transformation-2601/
3. https://www.marketscreener.com/news/gubra-launches-gubra-ventures-ce7e5adfdd80f623
4. https://www.gubra.dk/mfn_news/gubra-launches-gubra-ventures-and-appoints-zoe-johnson-to-lead-new-venture-creation-unit/
5. https://www.tradingview.com/news/modular_finance:2562a34429ef3:0-gubra-launches-gubra-ventures-and-appoints-zo-johnson-to-lead-new-venture-creation-unit/